SkylinePro

IBB - Biotech ETF could offer good potential

看多
SkylinePro 已更新   
NASDAQ:IBB   iShares Biotechnology ETF
IBB seems to have starting minor wave 5 up that could lead its price to the most probable target of 134.00. This sector should be be one of the good options to be in during the current market scenario. If prices crosses down 199.70, this analysis should be reviewed. FOLLOW SKYLINEPRO TO GET UPDATES.
交易結束:目標達成:
Prices reached 134.60 and should be start a correction to around the most probable target of 115.00. If prices crosses up 136, this scenario should be reviewed. See updated post

免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。